Travis S. Bradley

FDA investigator

Appears on 12 documents from 2018 to 2026, most often at sites in Switzerland. Most often cites production record review (21 CFR 211.192).

12
Documents on file
4.6
Observations per 483
2018
First seen
2026
Most recent

What they cite most

From 53 observations

Activity by year

2018: 3, 2022: 1, 2023: 2, 2024: 3, 2025: 2, 2026: 1

Where

Switzerland 2 · Austria 1 · Florida 1 · Germany 1 · Hungary 1 · New York 1

Is Travis S. Bradley coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

12 documents, newest first
FirmOpen
483 CSL Behring GmbH Emil-Von-Behring-Str. 76Feb 18, 2026 · Marburg, Germany
483 FDA Form 483 GlaxoSmithKline Biologicals Jan 2025Jan 31, 2025 · Godollo, Hungary
483 Form 483 · FEI 3008322822Jan 31, 2025
483 Wyeth Farma SANov 22, 2024 · San Sebastian de los Reyes, Spain
483 Catalent Pharma Solutions, LLCMay 24, 2024 · Morrisville, North Carolina
483 Kedrion Biopharma Inc.Mar 27, 2024 · Melville, New York
483 Regenerative Processing Plant, LLCJun 30, 2023 · Palm, Florida

About this profile

What does Travis S. Bradley inspect?

Travis S. Bradley appears on 12 documents on file covering 11 sites, most often in Switzerland.

What do they cite most often?

21 CFR 211.192 (production record review), followed by 21 CFR 211.42(a) and 21 CFR 211.67.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Travis S. Bradley is dated Feb 18, 2026.

FDA Investigator Travis S. Bradley: 483s & Inspections · FDA Intel